These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1678526

  • 1. Opioid mu and delta receptor antagonists reduce wet dog shaking elicited by perforant path stimulation.
    Mitchell CL, Barnes MI, Hudson PM, Hong JS.
    Pharmacol Biochem Behav; 1991 Apr; 38(4):801-5. PubMed ID: 1678526
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of the perforant path alters hippocampal levels of opioid peptides, glutamine and GABA.
    Mitchell CL, Grimes L, Hudson PM, Hong JS.
    Brain Res; 1987 Dec 01; 435(1-2):343-7. PubMed ID: 2892578
    [Abstract] [Full Text] [Related]

  • 3. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus.
    Mazarati A, Liu H, Wasterlain C.
    Neuroscience; 1999 Mar 01; 89(1):167-73. PubMed ID: 10051226
    [Abstract] [Full Text] [Related]

  • 4. Delta opioid receptor activation is required to induce LTP of synaptic transmission in the lateral perforant path in vivo.
    Bramham CR, Milgram NW, Srebro B.
    Brain Res; 1991 Dec 13; 567(1):42-50. PubMed ID: 1667745
    [Abstract] [Full Text] [Related]

  • 5. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC, Robles L, Mosberg HI.
    J Pharmacol Exp Ther; 1987 Feb 13; 240(2):571-7. PubMed ID: 3027318
    [Abstract] [Full Text] [Related]

  • 6. Colchicine lesions of ventral, but not dorsal, dentate granule cells attenuate wet dog shakes elicited by perforant path stimulation.
    Barnes MI, Mitchell CL.
    Brain Res; 1990 Mar 26; 512(1):159-63. PubMed ID: 2337804
    [Abstract] [Full Text] [Related]

  • 7. A glutamate antagonist blocks perforant path stimulation-induced reduction of dynorphin peptide and prodynorphin mRNA levels in rat hippocampus.
    Xie CW, McGinty JF, Lee PH, Mitchell CL, Hong JS.
    Brain Res; 1991 Oct 25; 562(2):243-50. PubMed ID: 1685342
    [Abstract] [Full Text] [Related]

  • 8. Perforant path stimulation differentially alters prodynorphin mRNA and proenkephalin mRNA levels in the entorhinal cortex-hippocampal region.
    Xie CW, Mitchell CL, Hong JS.
    Brain Res Mol Brain Res; 1990 Apr 25; 7(3):199-205. PubMed ID: 1970844
    [Abstract] [Full Text] [Related]

  • 9. Kainic acid as a tool to study the regulation and function of opioid peptides in the hippocampus.
    Hong JS, Grimes L, Kanamatsu T, McGinty JF.
    Toxicology; 1987 Oct 30; 46(2):141-57. PubMed ID: 2890224
    [Abstract] [Full Text] [Related]

  • 10. Opioids induce convulsions and wet dog shakes in rats: mediation by hippocampal mu, but not delta or kappa opioid receptors.
    Lee PH, Obie J, Hong JS.
    J Neurosci; 1989 Feb 30; 9(2):692-7. PubMed ID: 2537392
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
    Stevens KE, Shiotsu G, Stein L.
    Brain Res; 1991 Apr 05; 545(1-2):8-16. PubMed ID: 1677606
    [Abstract] [Full Text] [Related]

  • 12. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR, Makhlouf GM.
    Am J Physiol; 1991 Jan 05; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus.
    Wagner JJ, Caudle RM, Neumaier JF, Chavkin C.
    Neuroscience; 1990 Jan 05; 37(1):45-53. PubMed ID: 1978741
    [Abstract] [Full Text] [Related]

  • 14. Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release.
    Nikolarakis KE, Almeida OF, Yassouridis A, Herz A.
    Neuroscience; 1989 Jan 05; 31(1):269-73. PubMed ID: 2570378
    [Abstract] [Full Text] [Related]

  • 15. Hippocampal opioid peptides and seizures.
    Hong JS.
    Epilepsy Res Suppl; 1992 Jan 05; 7():187-95. PubMed ID: 1361330
    [Abstract] [Full Text] [Related]

  • 16. Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo.
    Do VH, Martinez CO, Martinez JL, Derrick BE.
    J Neurophysiol; 2002 Feb 05; 87(2):669-78. PubMed ID: 11826036
    [Abstract] [Full Text] [Related]

  • 17. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro.
    Piguet P, North RA.
    J Pharmacol Exp Ther; 1993 Aug 05; 266(2):1139-49. PubMed ID: 8394905
    [Abstract] [Full Text] [Related]

  • 18. Opioid enhancement of perforant path transmission: effect of an enkephalin analog on inhibition and facilitation in the dentate gyrus.
    Wiesner JB, Henriksen SJ, Bloom FE.
    Brain Res; 1986 Dec 10; 399(2):404-8. PubMed ID: 3030491
    [Abstract] [Full Text] [Related]

  • 19. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C, Henriksen SJ, Siggins GR, Bloom FE.
    Brain Res; 1985 Apr 08; 331(2):366-70. PubMed ID: 2859095
    [Abstract] [Full Text] [Related]

  • 20. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ, Green IC, Thorpe JR, Titheradge MA.
    Biochem J; 1990 Apr 01; 267(1):233-40. PubMed ID: 1970240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.